ConductScience.org, home

Paper41394271

An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastoma.

Jackson JW and 13 others. Mol Ther Oncol, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastoma. Papers, record 41394271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41394271

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastoma.
PubMed
Journal
Mol Ther Oncol
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2025-12-17
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jackson JWJoseph W
2Hall BLBonnie L
3Sneiderman CChaim
4Webb AAmy
5Hancock TJTrevor J
6Vlasyuk MMarina
7Bailey LLisa
8Xiaokui MMolly
9Solomon IHIsaac H
10Ligon KKeith
11Goins WFWilliam F
12Kohanbash GGary
13Chiocca EAE Antonio
14Glorioso JCJoseph C

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References81

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128214226CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin.Immunity2017https://conductscience.org/library/papers/28214226PubMed
231237234Circulating T cell-monocyte complexes are markers of immune perturbations.Elife2019https://conductscience.org/library/papers/31237234PubMed
331787969CD3+ Macrophages Deliver Proinflammatory Cytokines by a CD3- and Transmembrane TNF-Dependent Pathway and Are Increased at the BCG-Infection Site.Front Immunol2019https://conductscience.org/library/papers/31787969PubMed
410681459Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors.Proc Natl Acad Sci U S A2000https://conductscience.org/library/papers/10681459PubMed
534372501Oncolytic Viruses for Malignant Glioma: On the Verge of Success?Viruses2021https://conductscience.org/library/papers/34372501PubMed
623754388Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model.Proc Natl Acad Sci U S A2013https://conductscience.org/library/papers/23754388PubMed
733782623Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization.Nat Neurosci2021https://conductscience.org/library/papers/33782623PubMed
836700223Pre-clinical models for evaluating glioma targeted immunotherapies.Front Immunol2022https://conductscience.org/library/papers/36700223PubMed
929262845Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment.Genome Biol2017https://conductscience.org/library/papers/29262845PubMed
1016053696Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model.Neuro Oncol2005https://conductscience.org/library/papers/16053696PubMed
1130080893A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumors.PLoS Pathog2018https://conductscience.org/library/papers/30080893PubMed
1231792954The IFITM protein family in adaptive immunity.Immunology2020https://conductscience.org/library/papers/31792954PubMed
1333524948Safety and interim survival data after intracranial administration of M032, a genetically engineered oncolytic HSV-1 expressing IL-12, in pet dogs with sporadic gliomas.Neurosurg Focus2021https://conductscience.org/library/papers/33524948PubMed
1435798133Inflammatory type 2 conventional dendritic cells contribute to murine and human cholangitis.J Hepatol2022https://conductscience.org/library/papers/35798133PubMed
1533178203Localized Interleukin-12 for Cancer Immunotherapy.Front Immunol2020https://conductscience.org/library/papers/33178203PubMed
1625658639Glioma-associated microglia/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1.PLoS One2015https://conductscience.org/library/papers/25658639PubMed
1727314913
Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma.
Hum Gene Ther Clin Dev2016https://conductscience.org/library/papers/27314913PubMed
1829123084Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent.Nat Commun2017https://conductscience.org/library/papers/29123084PubMed
199574551In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity.J Immunol1998https://conductscience.org/library/papers/9574551PubMed
2035705536Ly6D+Siglec-H+ precursors contribute to conventional dendritic cells via a Zbtb46+Ly6D+ intermediary stage.Nat Commun2022https://conductscience.org/library/papers/35705536PubMed

See all 81 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42193877Reprogramming the Immunosuppressive Microenvironment in Glioblastoma Through Oncolytic Herpes Simplex Virus Therapy: A Systematic Review.Cells2026https://conductscience.org/library/papers/42193877PubMed
41951817Tumour trap: engineered enhancer sequences enlisted to kill cancer cells.Nature2026https://conductscience.org/library/papers/41951817PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41394271

GET https://conductscience.org/api/papers/v1/41394271/references?page=2